Atomera (ATOM)
Licenses MST transistor-enhancement technology, MSTcad software, and integration services to chipmakers.
$4.00
Pre-market+0.01 (+0.25%)
At close$3.99(+1.27%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 6 | 7 | |
| Research & development | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Operating income | −5 | −5 | −5 | −5 | −5 | −5 | −5 | −5 | −6 | −5 | −6 | −7 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −5 | −5 | −5 | −4 | −5 | −5 | −5 | −5 | −6 | −4 | −6 | −6 |
| Net income from continuing operations | −5 | −5 | −5 | −4 | −5 | −5 | −5 | −5 | −6 | −4 | −6 | −6 |
| Net income | −5 | −5 | −5 | −4 | −5 | −5 | −5 | −5 | −6 | −4 | −6 | −6 |
| EPS, basic | −$0.20 | −$0.18 | −$0.19 | −$0.16 | −$0.17 | −$0.17 | −$0.17 | −$0.16 | −$0.18 | −$0.14 | −$0.17 | −$0.17 |
| EPS, diluted | −$0.20 | −$0.18 | −$0.19 | −$0.16 | −$0.17 | −$0.17 | −$0.17 | −$0.16 | −$0.18 | −$0.14 | −$0.17 | −$0.17 |
| Weighted average shares, basic | 25 | 25 | 26 | 26 | 27 | 27 | 30 | 30 | 31 | 32 | 35 | 39 |
| Weighted average shares, diluted | 25 | 25 | 26 | 26 | 27 | 27 | 30 | 30 | 31 | 32 | 35 | 39 |
| EBITDA | −5 | −4 | −4 | −4 | −4 | −4 | −5 | −5 | −6 | −4 | −6 | −7 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −5 | −5 | −5 | −4 | −5 | −5 | −5 | −5 | −6 | −4 | −6 | −7 |
